| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 1 | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | 2 | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 45.26 | 19.83 | 18.06 | 22.10 |
| Receivables | 18.18 | 29.50 | 25.89 | 26.86 |
| Inventory | 20.09 | 26.84 | 31.58 | 27.92 |
| Other | — | — | — | — |
| 85.78 | 78.81 | 78.64 | 79.90 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 5.52 | 7.99 | 11.21 | 7.97 |
| ST’ Debt | 4.10 | 7.49 | 6.06 | 5.35 |
| Other | 5.28 | 4.99 | 6.39 | 5.46 |
| 24.30 | 31.95 | 35.76 | 32.13 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 33.89 | 35.31 | — | — |
—
|
| ’25 | 26.64 | 28.13 | 26.24 | 32.82 |
113.83
|
| ’24 | 29.82 | 33.99 | 30.27 | 36.60 |
130.69
|
| ’23 | 31.92 | 32.56 | 30.94 | 27.88 |
123.30
|
| ’22 | 24.08 | 29.57 | 30.77 | 32.41 |
116.83
|
| ’21 | 19.56 | 21.82 | 21.14 | 22.36 |
84.88
|
| ’20 | 11.23 | 13.28 | 14.44 | 14.88 |
53.82
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (3.31) | 6.32 | — | — |
—
|
| ’25 | 5.54 | (0.69) | 3.49 | (1.02) |
7.32
|
| ’24 | 2.08 | (5.09) | 4.25 | 2.59 |
3.82
|
| ’23 | 2.48 | 2.86 | 6.18 | 4.68 |
16.20
|
| ’22 | (2.79) | (2.29) | 1.42 | 2.27 |
(1.39)
|
| ’21 | (0.34) | 4.20 | 4.26 | 2.72 |
10.84
|
| ’20 | (0.12) | 0.20 | 2.32 | 0.85 |
3.25
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (3.96) | 5.91 | — | — |
—
|
| ’25 | 5.31 | (1.15) | 3.08 | (1.56) |
5.68
|
| ’24 | 1.74 | (5.41) | 3.74 | 2.42 |
2.50
|
| ’23 | 2.15 | 2.48 | 5.91 | 4.37 |
14.91
|
| ’22 | (3.12) | (2.67) | 1.09 | 1.95 |
(2.75)
|
| ’21 | (0.72) | 4.12 | 4.15 | 2.30 |
9.85
|
| ’20 | (0.20) | 0.09 | 1.99 | 0.72 |
2.60
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.06 | 0.04 | — | — |
—
|
| ’25 | (0.19) | (0.04) | (0.08) | 0.10 |
(0.21)
|
| ’24 | 0.05 | 0.02 | 0.04 | 0.12 |
0.24
|
| ’23 | 0.25 | 0.24 | 0.24 | 0.12 |
0.79
|
| ’22 | 0.05 | 0.20 | 0.23 | 0.30 |
0.78
|
| ’21 | 0.21 | 0.24 | 0.20 | 0.03 |
0.68
|
| ’20 | (0.11) | 0.02 | 0.04 | (0.04) |
(0.09)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 6.07 | 10.20 | 6.28 | 5.24 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 14.05 | 27.17 | 14.35 | 9.77 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 346 | 334 | 425 | 407 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.34 | 0.37 | 0.31 | 0.28 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 116.83 | 123.30 | 130.69 | 113.83 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.74% | 46.21% | 42.41% | 42.98% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.15 | 11.05 | 3.45 | (3.22) | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.68% | 8.96% | 2.64% | (2.83%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.46 | 9.34 | 2.89 | (2.53) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.52 | 6.73 | 7.25 | 8.41 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.95 | 10.76 | 10.75 | 9.33 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.79 | 0.82 | 0.24 | (0.21) | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.13) | 1.41 | 0.31 | 0.60 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.13) | (0.11) | (0.11) | (0.13) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.26) | 1.30 | 0.21 | 0.47 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.09 | 8.40 | 8.21 | 8.49 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.67 | 11.46 | 12.15 | 12.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 13.78 | 15.06 | 35.79 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.99 | 1.23 | 0.80 | 0.80 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.79 | 1.58 | 1.05 | 0.88 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.02 | 0.96 | 0.76 | 0.71 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (43.15) | 7.96 | 39.88 | 14.18 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.39) | 16.20 | 3.82 | 7.32 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.36) | (1.29) | (1.32) | (1.63) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.75) | 14.91 | 2.50 | 5.68 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.18 | 61.48 | 46.86 | 42.88 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.18 | 12.04 | 15.03 | 7.47 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.61 | (33.22) | (4.80) | (10.59) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 64.96 | 96.28 | 99.79 | 103.62 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.91% | 7.63% | 2.01% | (1.66%) | ‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.92% | 10.35% | 2.23% | (2.50%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.13% | 11.59% | 2.95% | (2.48%) | ‡‡‡‡ | — | — |
ROE
|
inTest Corporation (INTT), a key player in semiconductor test handling and thermal solutions, has shown impressive resilience through industry cycles, growing revenue from $40 million in 2016 to a 2024 peak of $130.7 million at a 17% CAGR, fueled by AI, 5G, and automotive demand. Despite a projected 14% revenue dip to $112 million in 2025 due to semiconductor inventory adjustments, forecasts point to a quick rebound toward $130 million by 2027, with operations scaling efficiently—revenue per employee steady at $300K-$370K even as headcount quadrupled.
Profitability faces short-term headwinds, with 2024 gross margins slipping to 42% and net income halving to $2.9 million, setting up a forecasted 2025 loss before recovery. Yet, free cash flow remains a bright spot, projected at $13 million in 2025 amid a cash-rich balance sheet (negative net debt) and strong book value per share at $8.21. Valuation looks compelling at 0.8x P/S and 1.05x P/B, especially with recent insider net buying signaling confidence during dips.
Stock volatility has created opportunities, trading sideways in 2024 despite revenue gains, while conservative analyst targets suggest modest upside. With AI tester demand ramping and FCF yields potentially topping 10%, INTT positions as an undervalued cyclical play for patient investors eyeing mid-teens returns post-trough.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.